Journal article
P-203 Rationale and design of three ongoing phase 1/2 trials of modakafusp alfa, an innate immunity enhancer, in patients with multiple myeloma: The innovate clinical development program
Authors
Mian H; Touzeau C; Holstein S; Kingsley E; Vogl D; Zuniga R; Kim K; Suryanarayan K; Wang S; Thesillat-Versmee L
Journal
Clinical Lymphoma Myeloma & Leukemia, Vol. 23, ,
Publisher
Elsevier
Publication Date
September 1, 2023
DOI
10.1016/s2152-2650(23)01821-9
ISSN
2152-2650